BIG
SRPT icon

Brooklyn Investment Group’s Sarepta Therapeutics SRPT Stock Holding History

Brooklyn Investment Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-368
Closed -$6.29K – 2413
2025
Q2 		$6.29K Sell
368
-353
-49% -$15.1K ﹤0.01% 2384
2025
Q1 		$46K Buy
721
+590
+450% +$62.1K 0.01% 818
2024
Q4 		$15.9K Sell
131
-24
-15% -$2.94K ﹤0.01% 818
2024
Q3 		$19.4K Buy
+155
New +$21.4K 0.01% 653

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Brooklyn Investment Group's SRPT Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 368 shares — an estimated $6.29K sold.

Brooklyn Investment Group first reported a position in SRPT in Q3 2024 and held it in 4 quarters. The position peaked at $46K in Q1 2025. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 368 Sarepta Therapeutics shares in Q3 2025, an estimated $6.29K.
  • Brooklyn Investment Group first reported a position in Sarepta Therapeutics in Q3 2024 and held it in 4 quarters.
  • Brooklyn Investment Group's Sarepta Therapeutics position peaked at $46K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.